This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
other
product name :
Calcein AM Cell Viability Assay
catalog :
4892-010-K
quantity :
1000 Tests
price :
238 USD
citations: 13
Reference
Kim S, Gates B, Chang M, Pinkerton K, VAN WINKLE L, Murphy C, et al. Transcorneal delivery of topically applied silver nanoparticles does not delay epithelial wound healing. NanoImpact. 2021;24:100352 pubmed publisher
Mörs K, Sturm R, Hörauf J, Kany S, Cavalli P, Omari J, et al. Anti-inflammatory Effects of Alcohol Are Associated with JNK-STAT3 Downregulation in an In Vitro Inflammation Model in HepG2 Cells. Dis Markers. 2021;2021:6622701 pubmed publisher
Ngwa C, Mamun A, Xu Y, Sharmeen R, Liu F. Phosphorylation of Microglial IRF5 and IRF4 by IRAK4 Regulates Inflammatory Responses to Ischemia. Cells. 2021;10: pubmed publisher
Liu Y, Kumblathan T, Uppal G, Zhou A, Moe B, Hrudey S, et al. A hidden risk: Survival and resuscitation of Escherichia coli O157:H7 in the viable but nonculturable state after boiling or microwaving. Water Res. 2020;183:116102 pubmed publisher
Hörauf J, Kany S, Janicova A, Xu B, Vrdoljak T, Sturm R, et al. Short Exposure to Ethanol Diminishes Caspase-1 and ASC Activation in Human HepG2 Cells In Vitro. Int J Mol Sci. 2020;21: pubmed publisher
Zaman S, Yu X, Bencivenga A, Blanden A, Liu Y, Withers T, et al. Combinatorial therapy of Zinc metallochaperones with mutant p53 reactivation and diminished copper binding. Mol Cancer Ther. 2019;: pubmed publisher
Lee J, Yesilkanal A, Wynne J, Frankenberger C, Liu J, Yan J, et al. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism. Nature. 2019;568:254-258 pubmed publisher
Olcina M, Balanis N, Kim R, Aksoy B, Kodysh J, Thompson M, et al. Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. Cell Rep. 2018;25:3721-3732.e6 pubmed publisher
Nguemgo Kouam P, Rezniczek G, Kochanneck A, Priesch Grzeszkowiak B, Hero T, Adamietz I, et al. Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells. PLoS ONE. 2018;13:e0198508 pubmed publisher
Zhang H, Sun F, Wang J, Xie L, Yang C, Pan M, et al. Combining Injectable Plasma Scaffold with Mesenchymal Stem/Stromal Cells for Repairing Infarct Cavity after Ischemic Stroke. Aging Dis. 2017;8:203-214 pubmed publisher
Diedrich J, Rajagurubandara E, Herroon M, Mahapatra G, Huttemann M, Podgorski I. Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation. Oncotarget. 2016;7:64854-64877 pubmed publisher
Giachin G, Narkiewicz J, Scaini D, Ngoc A, Margon A, Sequi P, et al. Prion protein interaction with soil humic substances: environmental implications. PLoS ONE. 2014;9:e100016 pubmed publisher
Swain L, Wottawa M, Hillemann A, Beneke A, Odagiri H, Terada K, et al. Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions. J Leukoc Biol. 2014;96:365-75 pubmed publisher
product information
brand :
R&D Systems
master code :
4892-010-K
SKU :
4892-010-K
product name :
Calcein AM Cell Viability Assay
target :
Cell Viability/Proliferation Assays
category :
Activity Assays
sizes available :
1000 Tests
species :
Multi-Species
USD :
226
USD 2023 :
238 USD
storage :
The product requires storage at -20 to -70 °C and room temperature. Consult the product insert for specific storage temperatures. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.